| __timestamp | Alnylam Pharmaceuticals, Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 190249000 | 12402000000 |
| Thursday, January 1, 2015 | 276495000 | 17449000000 |
| Friday, January 1, 2016 | 382392000 | 17834000000 |
| Sunday, January 1, 2017 | 390635000 | 19551000000 |
| Monday, January 1, 2018 | 505420000 | 18265000000 |
| Tuesday, January 1, 2019 | 655114000 | 15607000000 |
| Wednesday, January 1, 2020 | 654819000 | 15410000000 |
| Friday, January 1, 2021 | 792156000 | 16541000000 |
| Saturday, January 1, 2022 | 883015000 | 17482000000 |
| Sunday, January 1, 2023 | 1004415000 | 19381000000 |
| Monday, January 1, 2024 | 1126232000 | 22873000000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Alnylam Pharmaceuticals and Dr. Reddy's Laboratories have demonstrated contrasting strategies in their R&D investments. Alnylam's R&D expenses have surged by over 400% from 2014 to 2023, reflecting its aggressive pursuit of cutting-edge therapies. In contrast, Dr. Reddy's Laboratories, with a more stable R&D expenditure, has consistently invested around 17 times more than Alnylam annually, underscoring its focus on maintaining a broad portfolio of generic and proprietary drugs. Notably, 2024 data for Alnylam is missing, hinting at potential strategic shifts. This analysis highlights the diverse approaches these companies take in navigating the ever-evolving pharmaceutical industry, where innovation is key to staying ahead.
Comparing Innovation Spending: AstraZeneca PLC and Dr. Reddy's Laboratories Limited
R&D Insights: How Takeda Pharmaceutical Company Limited and Dr. Reddy's Laboratories Limited Allocate Funds
Breaking Down SG&A Expenses: Alnylam Pharmaceuticals, Inc. vs Dr. Reddy's Laboratories Limited
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc
Alnylam Pharmaceuticals, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and Dr. Reddy's Laboratories Limited
R&D Insights: How Dr. Reddy's Laboratories Limited and Exelixis, Inc. Allocate Funds
Dr. Reddy's Laboratories Limited or Bio-Techne Corporation: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Alkermes plc
Dr. Reddy's Laboratories Limited or Bausch Health Companies Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Agios Pharmaceuticals, Inc.
Research and Development Investment: Dr. Reddy's Laboratories Limited vs MiMedx Group, Inc.